BACKGROUND: Implantation of drug eluting stents (DESs) is currently the default approach for percutaneous coronary interventions, but long-term adverse events still exist. An approach with minimal ...
Interest in stenting for the treatment of symptomatic high-grade intracranial atherosclerosis may be rekindled after the results of a new trial showing lower rates of in-stent restenosis and stroke ...
Despite the impressive benefits obtained following the introduction of the drug-eluting stent, safety concerns have been raised over their long-term safety with particular regard to stent thrombosis.
Researchers have found in a new study that among patients with high bleeding risk, percutaneous coronary intervention using ...
Designed for Enhanced Deliverability and Flexibility to Treat Patients with Complex Coronary Artery Disease Built Upon the Proven Clinical Outcomes of Abbott's Cobalt Chromium Stent Technology, With a ...
LAS VEGAS and MARLBOROUGH, Mass., Oct. 6, 2021 /PRNewswire/ -- Today, Boston Scientific Corporation (NYSE: BSX) announced positive data for the Eluvia™ Drug-Eluting Vascular Stent System (Eluvia stent ...
COPD may increase cerebral microbleed risk Newer-generation drug-eluting stents reduce MI risk, target revascularization in women with coronary artery disease. Level 2: Mid-level evidence Drug-eluting ...
A new sub-study suggests that using a sirolimus-eluting balloon (SEB), a drug-coated balloon, can reduce the number of stents a patient may need, making it a safe and effective way to treat certain ...
A research team has demonstrated that clopidogrel is more effective than aspirin as a long-term antiplatelet therapy in patients at high risk of recurrent cardiovascular events after coronary stent ...
Drug-eluting stents are an established treatment option for coronary artery disease, although they are not without their problems. The MAHOROBA ® stent attempts to harness the theoretical advantages ...
The initial trials of drug-eluting stents (DESs) demonstrated marked reductions in restenosis and the need for repeat revascularization procedures, and resulted in the near instantaneous adoption of ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results